These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J. Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618 [Abstract] [Full Text] [Related]
23. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. Yang D, Kuan CT, Payne J, Kihara A, Murray A, Wang LM, Alimandi M, Pierce JH, Pastan I, Lippman ME. Clin Cancer Res; 1998 Apr 15; 4(4):993-1004. PubMed ID: 9563895 [Abstract] [Full Text] [Related]
26. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. Alper O, Yamaguchi K, Hitomi J, Honda S, Matsushima T, Abe K. Cell Growth Differ; 1990 Dec 15; 1(12):591-9. PubMed ID: 1981143 [Abstract] [Full Text] [Related]
28. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors. Schmitt M, Walker MP, Richards RG, Bocchinfuso WP, Fukuda T, Medina D, Kittrell FS, Korach KS, DiAugustine RP. Mol Carcinog; 2006 Jul 15; 45(7):490-505. PubMed ID: 16482517 [Abstract] [Full Text] [Related]
29. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R. Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689 [Abstract] [Full Text] [Related]
31. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. Xu F, Yu Y, Le XF, Boyer C, Mills GB, Bast RC. Clin Cancer Res; 1999 Nov 15; 5(11):3653-60. PubMed ID: 10589783 [Abstract] [Full Text] [Related]
35. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y. Oncogene; 1995 Apr 06; 10(7):1403-11. PubMed ID: 7731691 [Abstract] [Full Text] [Related]
36. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation. Giani C, Casalini P, Pupa SM, De Vecchi R, Ardini E, Colnaghi MI, Giordano A, Ménard S. Oncogene; 1998 Jul 30; 17(4):425-32. PubMed ID: 9696035 [Abstract] [Full Text] [Related]
37. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Oncogene; 1999 Jan 14; 18(2):305-14. PubMed ID: 9927187 [Abstract] [Full Text] [Related]